Literature DB >> 11060032

Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events.

R Beier1, A Bürgin, A Kiermaier, M Fero, H Karsunky, R Saffrich, T Möröy, W Ansorge, J Roberts, M Eilers.   

Abstract

The c-myc gene has been implicated in three distinct genetic programs regulating cell proliferation: control of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth. We have now used p27(-/-) fibroblasts to dissect these downstream signalling pathways. In these cells, activation of Myc stimulates transcription of E2F target genes, S-phase entry and cell growth without affecting cyclin E-cdk2 kinase activity. Both cyclin D2 and E2F2, potential direct target genes of Myc, are induced in p27(-/-) MycER cells. Ectopic expression of E2F2, but not of cyclin D2, induces S-phase entry, but, in contrast to Myc, does not stimulate cell growth. Our results show that stimulation of cyclin E-cdk2 kinase, of E2F-dependent transcription and of cell growth by Myc can be genetically separated from each other.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11060032      PMCID: PMC305784          DOI: 10.1093/emboj/19.21.5813

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  50 in total

Review 1.  Myc and the cell cycle.

Authors:  B Amati; K Alevizopoulos; J Vlach
Journal:  Front Biosci       Date:  1998-02-15

2.  Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation.

Authors:  R Y Poon; H Toyoshima; T Hunter
Journal:  Mol Biol Cell       Date:  1995-09       Impact factor: 4.138

3.  Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression.

Authors:  R C O'Hagan; M Ohh; G David; I M de Alboran; F W Alt; W G Kaelin; R A DePinho
Journal:  Genes Dev       Date:  2000-09-01       Impact factor: 11.361

4.  A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-02-25       Impact factor: 16.971

5.  Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc.

Authors:  I B Rosenwald; D B Rhoads; L D Callanan; K J Isselbacher; E V Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

6.  Differential modulation of cyclin gene expression by MYC.

Authors:  P Jansen-Dürr; A Meichle; P Steiner; M Pagano; K Finke; J Botz; J Wessbecher; G Draetta; M Eilers
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

7.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.

Authors:  T D Littlewood; D C Hancock; P S Danielian; M G Parker; G I Evan
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

8.  Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types.

Authors:  J Lukas; J Bartkova; M Welcker; O W Petersen; G Peters; M Strauss; J Bartek
Journal:  Oncogene       Date:  1995-06-01       Impact factor: 9.867

9.  The MYC protein activates transcription of the alpha-prothymosin gene.

Authors:  M Eilers; S Schirm; J M Bishop
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

10.  Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes.

Authors:  P Steiner; A Philipp; J Lukas; D Godden-Kent; M Pagano; S Mittnacht; J Bartek; M Eilers
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

View more
  33 in total

1.  N-myc promotes survival and induces S-phase entry of postmitotic sympathetic neurons.

Authors:  Kirmo Wartiovaara; Fanie Barnabe-Heider; Freda D Miller; David R Kaplan
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

2.  Cyclin E and chromosome instability in colorectal cancer cell lines.

Authors:  C Simone; N Resta; L Bagella; A Giordano; G Guanti
Journal:  Mol Pathol       Date:  2002-06

Review 3.  Cell cycle and apoptosis.

Authors:  Katrien Vermeulen; Zwi N Berneman; Dirk R Van Bockstaele
Journal:  Cell Prolif       Date:  2003-06       Impact factor: 6.831

Review 4.  Diet and prostate cancer: mechanisms of action and implications for chemoprevention.

Authors:  Vasundara Venkateswaran; Laurence H Klotz
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

Review 5.  MYC: connecting selective transcriptional control to global RNA production.

Authors:  Theresia R Kress; Arianna Sabò; Bruno Amati
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

6.  Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.

Authors:  C Elizabeth Caldon; C Marcelo Sergio; Judith Schütte; Marijke N Boersma; Robert L Sutherland; Jason S Carroll; Elizabeth A Musgrove
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

Review 7.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

8.  Commitment point during G0-->G1 that controls entry into the cell cycle.

Authors:  Nicholas C Lea; Stephen J Orr; Kai Stoeber; Gareth H Williams; Eric W-F Lam; Mohammad A A Ibrahim; Ghulam J Mufti; N Shaun B Thomas
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  Binding of herpes simplex virus type-1 virions leads to the induction of intracellular signalling in the absence of virus entry.

Authors:  Iain J MacLeod; Tony Minson
Journal:  PLoS One       Date:  2010-03-05       Impact factor: 3.240

10.  cMyc increases cell number through uncoupling of cell division from cell size in CHO cells.

Authors:  Darrin Kuystermans; Mohamed Al-Rubeai
Journal:  BMC Biotechnol       Date:  2009-09-07       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.